Joe and Bob Cardiovascular Webinar Series
THIS IS GETTING COMPLICATED...
How data from cardiovascular outcomes trials with diabetes drugs have changed the treatment landscape.
Get the Bottom Line on cardiovascular meds from CU Pharmacy experts -- Drs. Joe Saseen and Robert Page. This webinar will highlight recent clinical trial data regarding heart failure and diabetic kidney disease data with SGLT2i in addition to clinical trial data regarding cardiovascular risk reduction with SGLT2i and GLP1ra. In addition to evaluating the data surrounding Finerenone and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes.
Learning Objectives
- Highlight recent clinical trial data regarding heart failure and diabetic kidney disease data with SGLT2i
- Discuss recent clinical trial data regarding cardiovascular risk reduction with SGLT2i and GLP1ra
- Critically evaluate the data surrounding Finerenone and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes
About Joe and Bob
Joseph Saseen PharmD
Associate Dean for Clinical Affairs and Professor, Department of Clinical Pharmacy. Joseph Saseen is Associate Dean for Clinical Affairs and Professor of Clinical Pharmacy and a Professor of Family Medicine. He also served as Vice Chair of the Department of Clinical Pharmacy for 10 years. Dr. Saseen has responsibilities for enhancing the school’s clinical enterprise, further developing sustainable clinical service models, and advocating for advancing the practice of pharmacy in the State of Colorado. He is a clinical pharmacist at the University of Colorado Health focusing on cardiovascular risk reduction and population health. Dr. Saseen teaches cardiovascular pharmacotherapy and other topics related to primary care, and is the PGY2 Ambulatory Care residency program director. His scholarly work includes almost 200 peer-reviewed publications and book chapters.
| Robert Page II PharmD, MSPH, BCPS (AQ-cards), BCGP, FAHA, FHFSA, FCCP, FASHP
Professor, Departments of Clinical Pharmacy and Physical Medicine. Dr. Page, practices in Inpatient cardiology service and heart failure/transplant service at University Hospital, and serves on two committees of the American Heart Association where his contributions have demonstrated the expanse of drug knowledge that pharmacists bring to a multidisciplinary team. Dr. Page was recently awarded Excellence in Teaching from the University of Colorado Skaggs School of Pharmacy and the President's Teaching Award from University of Colorado.
|
CPE Accreditation

THIS IS GETTING COMPLICATED... How data from cardiovascular outcomes trials with diabetes drugs have changed the treatment landscape.
UAN #0008-0000-21-109-H04-P/T, release: 01/05/2022, expiry 01/05/2025, 1.0 contact hours/0.1 CEU
The University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). This activity has been accredited for 1.0 contact hours of knowledge-based continuing pharmacy education. Participates will be provided instructions on how to claim CPE Credit after the webinar.